Πλοήγηση ανά Συγγραφέα "Norman, G. L."
-
Antibody responses specific for soluble liver antigen co-occur with RO-52 autoantibodies in patients with autoimmune hepatitis
Liaskos, C.; Bogdanos, D. P.; Rigopoulou, E. I.; Norman, G. L.; Shurns, Z.; Al-Chalabi, T.; Krawitt, E. L.; Mieli-Vergani, G.; Czaja, A. J.; Vergani, D.; Dalekos, G. N. (2007) -
Cartilage oligomeric matrix protein (COMP) serum levels: a new non-invasive biomarker of liver fibrosis in patients with chronic viral hepatitis
Gabeta, S.; Zachou, K.; Shums, Z.; Gatselis, N.; Koukoulis, G. K.; Norman, G. L.; Dalekos, G. N. (2014) -
Cartilage oligomeric matrix protein (COMP): A novel non-invasive marker for assessing liver cirrhosis and risk of progression to hepatocellular carcinoma
Norman, G. L.; Gatselis, N.; Shums, Z.; Liaskos, C.; Bogdanos, D. P.; Koukoulis, G. K.; Dalekos, G. N. (2014) -
Cartilage oligomeric matrix protein: A novel non-invasive marker for assessing cirrhosis and risk of hepatocellular carcinoma
Norman, G. L.; Gatselis, N. K.; Shums, Z.; Liaskos, C.; Bogdanos, D. P.; Koukoulis, G. K.; Dalekos, G. N. (2015)AIM: To assess serum cartilage oligomeric matrix protein (COMP) as a marker of cirrhosis and risk of progression to hepatocellular carcinoma (HCC). METHODS: A COMP enzyme-linked immunosorbent assay was used to test 187 ... -
Chronic hepatitis C is characterised by an interferon-alpha induced novel autoantibody giving a crescent pattern by indirect immunofluorescence
Liaskos, C.; Bogdanos, D. P.; Gatselis, N.; Horner, D.; Shums, Z.; Murphy, D.; Rigopoulou, E. I.; Smith, H.; Vergani, D.; Norman, G. L.; Dalekos, G. N. (2007) -
CLINICAL SIGNIFICANCE OF THE FLUCTUATION OF PRIMARY BILIARY CIRRHOSIS-RELATED AUTOANTIBODIES DURING THE COURSE OF THE DISEASE
Gatselis, N. K.; Zachou, K.; Norman, G. L.; Gabeta, S.; Koukoulis, G. K.; Dalekos, G. N. (2012) -
Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the disease
Gatselis, N. K.; Zachou, K.; Norman, G. L.; Gabeta, S.; Papamichalis, P.; Koukoulis, G. K.; Dalekos, G. N. (2013)Primary biliary cirrhosis (PBC) is a chronic cholestatic disease characterized by the presence of antimitochondrial antibodies (AMA). PBC-specific antinuclear antibodies (ANA) have been characterized and associated with ... -
Diagnostic and clinical significance of Crohn's disease-specific anti-MZGP2 pancreatic antibodies by a novel ELISA
Pavlidis, P.; Shums, Z.; Koutsoumpas, A. L.; Milo, J.; Papp, M.; Umemura, T.; Lakatos, P. L.; Smyk, D. S.; Bogdanos, D. P.; Forbes, A.; Norman, G. L. (2015)Background: We developed a new IgA and IgG anti-MZGP2 antibody ELISAs based on recombinant isoform-4 of human zymogen granule protein-2 (GP2), which is the major autoantigen of Crohn's disease (CrD)-specific pancreatic ... -
Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis
Gabeta, S.; Norman, G. L.; Liaskos, C.; Papamichalis, P. A.; Zografos, T.; Garagounis, A.; Rigopoulou, E. I.; Dalekos, G. N. (2007)Background/aims: Antimitochondrial antibodies (AMAs) are the serological hallmark of primary biliary cirrhosis (PBC). We evaluated the sensitivity and specificity of a new M2 enhanced performance enzyme-linked immunosorbent ... -
IgA anti-b2GPI antibodies in patients with autoimmune liver diseases
Gabeta, S.; Norman, G. L.; Gatselis, N.; Liaskos, C.; Papamichalis, P. A.; Garagounis, A.; Zachou, K.; Rigopoulou, E. I.; Dalekos, G. N. (2008)Introduction Recently, we reported a high prevalence of immunoglobulin G and/or immunoglobulin M anticardiolipin antibodies (aCL) in patients with autoimmune liver diseases, namely, autoimmune hepatitis (AIH), primary ... -
IGA ANTIBODIES AGAINST DEAMIDATED GLIADIN PEPTIDES AND TISSUE-TRANSGLUTAMINASE IN PATIENTS WITH CHRONIC LIVER DISEASES
Gatselis, N. K.; Zachou, K.; Norman, G. L.; Tzelas, G.; Gabeta, S.; Speletas, M.; Koukoulis, G. K.; Dalekos, G. N. (2012) -
IgA antibodies against deamidated gliadin peptides in patients with chronic liver diseases
Gatselis, N. K.; Zachou, K.; Norman, G. L.; Tzellas, G.; Speletas, M.; Gabeta, S.; Germenis, A.; Koukoulis, G. K.; Dalekos, G. N. (2012)Background/aims: IgA antibodies against tissue-transglutaminase (anti-tTG-IgA) and IgA and IgG antibodies against deamidated gliadin peptides (anti-DGP-IgA and anti-DGP-IgG) are considered specific for celiac disease (CD) ... -
IgA isotype specific anti-b2GPI antibodies in patients with autoimmune liver diseases
Gabeta, S.; Norman, G. L.; Gatselis, N.; Liaskos, C.; Papamichalis, P. A.; Garagounis, A.; Zachou, K.; Rigopoulou, E. I.; Dalekos, G. N. (2008) -
New sensitive technique for the detection of anti-smooth muscle antibodies in autoimmune hepatitis
Liaskos, C.; Mytilinaiou, M. G.; Grammatikopoulos, A.; Smyk, D. S.; Orfanidou, T.; Mavropoulos, A.; Norman, G. L.; Rigopoulou, E. I.; Mieli-Vergani, G.; Bogdanos, D. P.; Vergani, D. (2012) -
PBC Screen: An IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis
Liu, H.; Norman, G. L.; Shums, Z.; Worman, H. J.; Krawitt, E. L.; Bizzaro, N.; Vergani, D.; Bogdanos, D. P.; Dalekos, G. N.; Milkiewicz, P.; Czaja, A. J.; Heathcote, E. J.; Hirschfield, G. M.; Tan, E. M.; Miyachi, K.; Bignotto, M.; Battezzati, P. M.; Lleo, A.; Leung, P. S.; Podda, M.; Gershwin, M. E.; Invernizzi, P. (2010)A dual isotype (IgG, IgA) enzyme-linked immunosorbent assay (ELISA) designed to provide enhanced detection of primary biliary cirrhosis (PBC)-specific autoantibodies against both major mitochondrial and nuclear antigens ... -
Prevalence of gastric parietal cell antibodies and intrinsic factor antibodies in primary biliary cirrhosis
Liaskos, C.; Norman, G. L.; Moulas, A.; Garagounis, A.; Goulis, I.; Rigopoulou, E. I.; Dalekos, G. N. (2010)Background: We investigated the prevalence of antibodies against gastric parietal cells (GPA), intrinsic factor antibodies (IFA) and the presence of pernicious anemia in a large cohort of primary biliary cirrhosis (PBC) ...